BPG is committed to discovery and dissemination of knowledge
Welcome to the Artificial Intelligence in Cancer

Artificial Intelligence in Cancer (AIC, Artif Intell Cancer) is a high-quality, open-access academic journal that employs a single-blind peer-review process. The journal focuses on publishing innovative, novel, and practical clinical, basic, and translational research achievements in the fields of artificial intelligence in cancer. The types of articles published in AIC include Editorial, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. All submissions must comply with academic norms and ethical requirements. The journal is edited and published by the Baishideng Publishing Group. Submit here >>

2025 Published Issues
1
Editors-in-Chief
  • Cedric Coulouarn, PhD, Senior Researcher, (Email: cedric.coulouarn@inserm.fr) Institut National de la Sante et de la Recherche Medicale, Univ Rennes, Rennes 35033, France
Indexing/Abstracting

The AIC is now abstracted and indexed in Reference Citation Analysis, China Science and Technology Journal Database.

Journal Metrics

There is currently no impact factor.

ISSN
2644-3228 (online)
Latest Manuscript Statistics
Received (3), Peer Review Time (5 days/Mean), Time to First Decision (42 days/Mean), Second Decision Time (25 days/Mean), Accepted (33.3%/Mean), Production Time (40 days/Mean), Time to Publication (103 days/Mean), and Rejected (0.0%/Mean).